李春權

李春權

哈爾濱醫科大學，大慶校區醫學信息學院，教授，博士，碩士研究生導師。

於維漢院士傑出青年培養基金獲得者，黑龍江省優秀博士論文獲得者，哈爾濱醫科大學十大青年科技人才獎獲得者，人民衛生出版社出版《生物信息學理論與醫學實踐》一書擔任編委， 全國性生物信息學培訓班教師（共三期），全國生物信息暑期學校培訓教師，全國生物信息骨幹教師培訓班講座教師。研究方向是“複雜疾病相關的代謝通路重構、分析和識別”。

基本介紹

  • 中文名：李春權
  • 外文名：Li C/Li CQ
  • 國籍：中國
  • 民族：朝鮮族
  • 出生日期：1979年
  • 職業：教授，博士，碩士研究生導師
  • 畢業院校：哈爾濱醫科大學生物信息學院
學術兼職,教育與工作經歷,教育經歷,研究工作經歷,研究方向,項目與獲獎,主持的科研項目,參加的科研項目,榮譽稱號,代表性學術論文,2019,2018,2017,2016,2015,2014,2013,2012,2011,2009,

學術兼職

  • 《生物信息學理論與醫學實踐》（人民衛生出版社出版）擔任編委
  • 全國性生物信息學培訓班教師（共三期）
  • 全國生物信息暑期學校培訓教師
  • 全國生物信息骨幹教師培訓班講座教師

教育與工作經歷

教育經歷

研究工作經歷

  • 2012/10 - 至今，哈爾濱醫科大學，生物信息科學與技術學院/大慶校區醫學信息學院，副教授。
  • 2009/10-2012/09，哈爾濱醫科大學，生物信息科學與技術學院，講師。
  • 2005/08-2009/09，哈爾濱醫科大學，生物信息科學與技術學院，助教。

研究方向

複雜疾病相關的代謝通路重構、分析和識別。

項目與獲獎

主持的科研項目

  • 國家自然科學基金面上項目，食管癌中非編碼RNA調控的代謝通路高異常區域識別及其分子互作機制、2016/1-2019/12、67.8萬元、在研、主持。
  • 於維漢院士傑出青年培養基金項目，2014/07-2017/06、30萬元、在研、主持。
  • 黑龍江省自然科學基金面上項目，2016/07-2019/07、整合microRNA與mRNA表達譜識別複雜疾病風險通路、6萬元、在研、主持。
  • 國家自然科學基金青年項目，整合高通量基因、代謝子和通路結構信息的癌症風險代謝通路區域系統識別、2013/1-2015/12、22萬元、結題、主持。
  • 黑龍江省教育廳項目，複雜疾病風險代謝通路整合識別方法研究，2013/1-2015/12、2萬元、在研、主持。
  • 國家教育部高等學校博士點學科專項科研基金項目，疾病代謝子通路融合挖掘及網路分析方法研究、2011/01-2013/12、3.6萬元、已結題、主持。
  • 黑龍江省研究生創新基金（重點）項目，融合基因組和代謝組進行複雜疾病風險代謝通路區域精細識別、2011/9-2012/7、5萬元、已結題、申請人。

參加的科研項目

  • 國家自然科學基金重大研究計畫項目，融合組學挖掘非可控性炎症向癌症轉化的分子機制、2011/1-2013/12、60萬、已結題、參加。
  • 國家自然科學基金面上項目，複雜疾病關聯的miRNA-mRNA功能模組識別的信息融合方法研究、2009/1-2011/12、33萬元、已結題、參加。

榮譽稱號

  • 於維漢院士傑出青年培養基金獲得者
  • 黑龍江省優秀博士論文獲得者
  • 哈爾濱醫科大學十大青年科技人才獎獲得者

代表性學術論文

（標記#者為共同第一作者，標記*者為通訊或共同通訊作者）

2019

  1. Jiang Y, Qian F, Bai X, Liu Y, Wang Q, Ai B, Han X, Shi S, Zhang J, Li X, Tang Z, Pan Q, Wang Y, Wang F, Li C (李春權). SEdb: a comprehensive human super-enhancer database. Nucleic Acids Res. 2019 Jan 8;47(D1):D235-D243. doi: 10.1093/nar/gky1025. PubMed PMID: 30371817; PubMed Central PMCID: PMC6323980.
  2. NingZ#,FengC#,SongC#,LiuW,ShangD,LiM,WangQ,ZhaoJ,LiuY,ChenJ,YuX*,ZhangJ*,LiC (李春權)* .Topologically inferring active miRNA-mediated subpathways toward precise cancer classification by directed random walk. Mol Oncol. 2019 Aug 13.
  3. Li M#, Zhao J#, Li X#, Chen Y, Feng C, Qian F, Liu Y, Zhang J, He J, Ai B, Ning Z, Liu W, Bai X, Han X, Wu Z, Xu X, Tang Z, Pan Q, Xu L, Li C (李春權)* , Wang Q*, Li E*. HiFreSP: A novel high-frequency sub-pathway mining approach to identify robust prognostic gene signatures. Brief Bioinform. 2019 Jul 27. pii: bbz078. doi: 10.1093/bib/bbz078. [Epub ahead of print] PubMed PMID: 31350847.
  4. Zhao J#, Li X#, Guo J#, Li M, Zhang J, Ding J, Li S, Tang Z, Qian F, Li Y, Wang Q, Li C (李春權)* , Li E*, Xu L*. ReCirc: prediction of circRNA expression and function through probe reannotation of non-circRNA microarrays. Mol Omics. 2019 Apr 1;15(2):150-163. doi: 10.1039/c8mo00252e. Epub 2019 Mar 27. PubMed PMID: 30916068.
  5. Qian FC#, Li XC#, Guo JC#, Zhao JM, Li YY, Tang ZD, Zhou LW, Zhang J, Bai XF, Jiang Y, Pan Q, Wang QY, Li EM, Li CQ(李春權)* , Xu LY, * Lin DC*. SEanalysis: a web tool for super-enhancer associated regulatory analysis. Nucleic Acids Res. 2019 Jul 2;47(W1):W248-W255. doi: 10.1093/nar/gkz302. PubMed PMID: 31028388; PubMed Central PMCID: PMC6602466.

2018

  1. Feng C#, Song C#, Ning Z#, Ai B, Wang Q, Xu Y, Li M, Bai X, Zhao J, Liu Y, Li X, Zhang J, Li C (李春權)* . ce-Subpathway: Identification of ceRNA-mediated subpathways via joint power of ceRNAs and pathway topologies. J Cell Mol Med. 2019 Feb;23(2):967-984. doi: 10.1111/jcmm.13997. Epub 2018 Nov 12. PubMed PMID: 30421585; PubMed Central PMCID: PMC6349186.
  2. Jiang Y, Jiang YY, Xie JJ, Mayakonda A, Hazawa M, Chen L, Xiao JF, Li CQ (李春權), Huang ML, Ding LW, Sun QY, Xu L, Kanojia D, Jeitany M, Deng JW, Liao LD, Soukiasian HJ, Berman BP, Hao JJ, Xu LY, Li EM, Wang MR, Bi XG, Lin DC, Koeffler HP. Co-activation of super-enhancer-driven CCAT1 by TP63 and SOX2 promotes squamous cancer progression. Nat Commun. 2018 Sep 6;9(1):3619. doi: 10.1038/s41467-018-06081-9. PubMed PMID: 30190462; PubMed Central PMCID: PMC6127298.
  3. Tang Z, Li X, Zhao J, Qian F, Feng C, Li Y, Zhang J, Jiang Y, Yang Y, Wang Q,Li C (李春權). TRCirc: a resource for transcriptional regulation information of circRNAs. Brief Bioinform. 2018 Sep 3. doi: 10.1093/bib/bby083. [Epub ahead of print] PubMed PMID: 30184150.
  4. Han J, Liu S, Jiang Y, Xu C, Zheng B, Jiang M, Yang H, Su F, Li C (李春權), Zhang Y. Inference of patient-specific subpathway activities reveals a functional signature associated with the prognosis of patients with breast cancer. J Cell Mol Med. 2018 Sep;22(9):4304-4316. doi: 10.1111/jcmm.13720. Epub 2018 Jul 4. PubMed PMID: 29971923; PubMed Central PMCID: PMC6111825.
  5. Liu W, He JZ, Wang SH, Liu DK, Bai XF, Xu XE, Wu JY, Jiang Y, Li CQ (李春權), Chen LQ, Li EM, Xu LY. MASAN: a novel staging system for prognosis of patients with oesophageal squamous cell carcinoma. Br J Cancer. 2018 May;118(11):1476-1484. doi: 10.1038/s41416-018-0094-x. Epub 2018 May 16. PubMed PMID: 29765149; PubMed Central PMCID: PMC5988697.
  6. Huang GW, Xue YJ, Wu ZY, Xu XE, Wu JY, Cao HH, Zhu Y, He JZ, Li CQ (李春權), Li EM, Xu LY. A three-lncRNA signature predicts overall survival and disease-free survival in patients with esophageal squamous cell carcinoma. BMC Cancer. 2018 Feb 6;18(1):147. doi: 10.1186/s12885-018-4058-6. PubMed PMID: 29409459; PubMed Central PMCID: PMC5801805.
  7. Xie JJ, Jiang YY, Jiang Y, Li CQ (李春權), Lim MC, An O, Mayakonda A, Ding LW, Long L, Sun C, Lin LH, Chen L, Wu JY, Wu ZY, Cao Q, Fang WK, Yang W, Soukiasian H, Meltzer SJ, Yang H, Fullwood M, Xu LY, Li EM, Lin DC, Koeffler HP. Super-Enhancer-Driven Long Non-Coding RNA LINC01503, Regulated by TP63, Is Over-Expressed and Oncogenic in Squamous Cell Carcinoma. Gastroenterology. 2018 Jun;154(8):2137-2151.e1. doi: 10.1053/j.gastro.2018.02.018. Epub 2018 Feb 15. PubMed PMID: 29454790.

2017

  1. Lin DC, Dinh HQ, Xie JJ, Mayakonda A, Silva TC, Jiang YY, Ding LW, He JZ, Xu XE, Hao JJ, Wang MR, Li C (李春權), Xu LY, Li EM, Berman BP, Phillip Koeffler H. Identification of distinct mutational patterns and new driver genes in oesophageal squamous cell carcinomas and adenocarcinomas. Gut. 2018 Oct;67(10):1769-1779. doi: 10.1136/gutjnl-2017-314607. Epub 2017 Aug 31. PubMed PMID: 28860350; PubMed Central PMCID: PMC5980794.
  2. Yang H, Shang D, Xu Y, Zhang C, Feng L, Sun Z, Shi X, Zhang Y, Han J, Su F, Li C (李春權), Li X. The LncRNA Connectivity Map: Using LncRNA Signatures to Connect Small Molecules, LncRNAs, and Diseases. Sci Rep. 2017 Jul 27;7(1):6655. doi: 10.1038/s41598-017-06897-3. PubMed PMID: 28751672; PubMed Central PMCID: PMC5532316.
  3. Zhan XH, Jiao JW, Zhang HF, Li CQ (李春權), Zhao JM, Liao LD, Wu JY, Wu BL, Wu ZY, Wang SH, Du ZP, Shen JH, Zou HY, Neufeld G, Xu LY, Li EM. A three-gene signature from protein-protein interaction network of LOXL2- and actin-related proteins for esophageal squamous cell carcinoma prognosis. Cancer Med. 2017 Jul;6(7):1707-1719. doi: 10.1002/cam4.1096. Epub 2017 May 29. PubMed PMID: 28556501; PubMed Central PMCID: PMC5504325.
  4. Zhang J, Feng C, Song C, Ai B, Bai X, Liu Y, Li X, Zhao J, Shi S, Chen X, Su X, Li C (李春權). Identification and analysis of a key long non-coding RNAs (lncRNAs)-associated module reveal functional lncRNAs in cardiac hypertrophy. J Cell Mol Med. 2018 Feb;22(2):892-903. doi: 10.1111/jcmm.13376. Epub 2017 Nov 20. PubMed PMID: 29154475; PubMed Central PMCID: PMC5783834.
  5. Han J, Liu S, Sun Z, Zhang Y, Zhang F, Zhang C, Shang D, Yang H, Su F, Xu Y, Li C (李春權), Ren H, Li X. LncRNAs2Pathways: Identifying the pathways influenced by a set of lncRNAs of interest based on a global network propagation method. Sci Rep. 2017 Apr 20;7:46566. doi: 10.1038/srep46566. PubMed PMID: 28425476; PubMed Central PMCID: PMC5397852.
  6. Song C, Zhang J, Qi H, Feng C, Chen Y, Cao Y, Ba L, Ai B, Wang Q, Huang W, Li C (李春權), Sun H. The global view of mRNA-related ceRNA cross-talks across cardiovascular diseases. Sci Rep. 2017 Aug 31;7(1):10185. doi: 10.1038/s41598-017-10547-z. Erratum in: Sci Rep. 2018 Jul 17;8(1):11019. PubMed PMID: 28860540; PubMed Central PMCID: PMC5579186.
  7. Li C (李春權), Wang Q, Ma J, Shi S, Chen X, Yang H, Han J. Integrative Pathway Analysis of Genes and Metabolites Reveals Metabolism Abnormal Subpathway Regions and Modules in Esophageal Squamous Cell Carcinoma. Molecules. 2017 Sep 22;22(10). pii: E1599. doi: 10.3390/molecules22101599. PubMed PMID: 28937628; PubMed Central PMCID: PMC6151487.
  8. Li CQ (李春權), Huang GW, Wu ZY, Xu YJ, Li XC, Xue YJ, Zhu Y, Zhao JM, Li M, Zhang J, Wu JY, Lei F, Wang QY, Li S, Zheng CP, Ai B, Tang ZD, Feng CC, Liao LD, Wang SH, Shen JH, Liu YJ, Bai XF, He JZ, Cao HH, Wu BL, Wang MR, Lin DC, Koeffler HP, Wang LD, Li X, Li EM, Xu LY. Integrative analyses of transcriptome sequencing identify novel functional lncRNAs in esophageal squamous cell carcinoma. Oncogenesis. 2017 Feb 13;6(2):e297. doi: 10.1038/oncsis.2017.1. PubMed PMID: 28194033; PubMed Central PMCID: PMC5337622.

2016

  1. Song C, Zhang J, Liu Y, Pan H, Qi HP, Cao YG, Zhao JM, Li S, Guo J, Sun HL*, Li CQ (李春權)*. Construction and analysis of cardiac hypertrophy-associated lncRNA-mRNA network based on competitive endogenous RNA reveal functional lncRNAs in cardiac hypertrophy. Oncotarget. 2016 Mar 8;7(10):10827-40.
  2. Feng C#, Zhang J#, Li X#, Ai B, Han J, Wang Q, Wei T, Xu Y, Li M, Li S, Song C,Li C (李春權)*. Subpathway-CorSP: Identification of metabolic subpathways via integrating expression correlations and topological features between metabolites and genes of interest within pathways. Sci Rep. 2016 Sep 14;6:33262.
  3. Li S, Xu Y, Sun Z, Feng L, Shang D, Zhang C, Shi X, Han J, Su F, Yang H, Zhao J, Song C, Zhang Y, Li C (李春權)*, Li X*. Identification of a lncRNA involved functional module for esophageal cancer subtypes. Mol Biosyst. 2016 Aug 19. PubMed PMID: 27539139.
  4. Zhao J#, Li X#,Yao Q#, Li M, Zhang J, Ai B, Liu W, Wang Q, Feng C, Liu Y, Bai X, Song C, Li S, Li E, Xu L*, Li C (李春權)*. RWCFusion: identifying phenotype-specific cancer driver gene fusions based on fusion pair random walk scoring method. Oncotarget. 2016 Aug 5. PubMed PMID: 27506935.
  5. Shi X#, Xu Y#, Zhang C, Feng L, Sun Z, Han J, Su F, Zhang Y*,Li C (李春權)*, Li X*. Subpathway-LNCE: Identify dysfunctional subpathways competitively regulated by lncRNAs through integrating lncRNA-mRNA expression profile and pathway topologies. Oncotarget. 2016 Sep 13. PubMed PMID:27634882.
  6. Han J#, Liu S#, Zhang Y#, Xu Y, Jiang Y, Zhang C, Li C (李春權)*, Li X*. MiRSEA: Discovering the pathways regulated by dysfunctional MicroRNAs. Oncotarget. 2016 Jul 26. PubMed PMID: 27474169.
  7. Guo JC, Li CQ(李春權), Wang QY, Zhao JM, Ding JY, Li EM*, Xu LY*.Mol Biosyst. 2016 Sep 23. PubMed PMID: 27714034.
  8. Zou HY, Lv GQ, Dai LH, Zhan XH, Jiao JW, Liao LD, Zhou TM,Li CQ (李春權), Wu BL, Xu LY*, Li EM*. A truncated splice variant of human lysyl oxidase-like 2 promotes migration and invasion in esophageal squamous cell carcinoma. Int J Biochem Cell Biol. 2016 Jun;75:85-98.

2015

  1. Liu W, Bai X, Liu Y, Wang W, Han J, Wang Q, Xu Y, Zhang C, Zhang S, Li X, Ren Z, Zhang J*, Li C (李春權)*. Topologically inferring pathway activity toward precise cancer classification via integrating genomic and metabolomic data: prostate cancer as a case. Sci Rep. 2015 Aug 19;5:13192. （SCI影響因子IF=5.5）
  2. Feng L, Xu Y, Zhang Y, Sun Z, Han J, Zhang C, Yang H, Shang D, Su F, Shi X, Li S, Li C (李春權)*, Li X*. . Oncotarget. 2015 Oct 12. doi: 10.18632/oncotarget.5341.（SCI影響因子IF=6.3）
  3. Han J, Shi X, Zhang Y, Xu Y, Jiang Y, Zhang C, Feng L, Yang H, Shang D, Sun Z, Su F, Li C (李春權)*, Li X*. ESEA: Discovering the Dysregulated Pathways based on Edge Set Enrichment Analysis. Sci Rep. 2015 Aug 12;5:13044. doi: 10.1038/srep13044. （SCI影響因子IF=5.5）
  4. Lv W, Wang Q, Chen H, Jiang Y, Zheng J, Shi M, Xu Y, Han J, Li C (李春權)*, Zhang R*. Prioritization of rheumatoid arthritis risk subpathways based on global immune subpathway interaction network and random walk strategy. Mol Biosyst. 2015 Oct 13;11(11):2986-97.
  5. Liu W, Wang Q, Zhao J, Zhang C, Liu Y, Zhang J, Bai X, Li X, Feng H, Liao M, Wang W*, Li C (李春權)*. Integration of pathway structure information into a reweighted partial Cox regression approach for survival analysis on high-dimensional gene expression data. Mol Biosyst. 2015 Jul;11(7):1876-86.
  6. Zhang J, Wang Y, Shang D, Yu F, Liu W, Zhang Y, Feng C, Wang Q, Xu Y, Liu Y, Bai X, Li X, Li C (李春權)*. Characterizing and optimizing human anticancer drug targets based on topological properties in the context of biological pathways. J Biomed Inform. 2015 Apr;54:132-140.
  7. Shang D, Yang H, Xu Y, Yao Q, Zhou W, Shi X, Han J, Su F, Su B, Zhang C, Li C (李春權)*, Li X*. A global view of network of lncRNAs and their binding proteins. Mol Biosyst. 2015 Feb;11(2):656-663.
  8. Deng L, Xu Y, Zhang C, Yao Q, Feng L, Li C (李春權)*. A network-based strategy from the global perspective for identification of risk pathways in complex diseases. Prog Biochem Biophys. 2015 Jan 15;42(3):11.
  9. Zhang C, Li C (李春權), Xu Y, Feng L, Shang D, Yang X, Han J, Sun Z, Li Y*, Li X Mol Biosyst. 2015 May; PubMed PMID: 25720795.
  10. Han J, Li C (李春權), Yang H, Xu Y, Zhang C, Ma J, Shi X, Liu W, Shang D, Yao Q, Zhang Y, Su F, Feng L, Li X*. Journal of the Royal Society Interface. 2015 Jan 6;12(102):20140937.
  11. Chen X, Wang Y, Wang P, Lian B, Li C (李春權), Wang J, Li X, Jiang W. Systematic Analysis of the Associations between Adverse Drug Reactions and Pathways. Biomed Res Int. 2015;2015:670949.
  12. Zhang Y, Liu W, Xu Y, Li C (李春權), Wang Y, Yang H, Zhang C, Su F, Li Y*, Li X*. Identification of subtype specific miRNA-mRNA functional regulatory modules in matched miRNA-mRNA expression data: multiple myeloma as a case. Biomed Res Int. 2015 Mar 19;2015:501262.
  13. Yao Q, Xu Y, Yang H, Shang D, Zhang C, Zhang Y, Sun Z, Shi X, Feng L, Han J, Su F, Li C (李春權)*, Li X*. Global Prioritization of Disease Candidate Metabolites Based on a Multi-omics Composite Network. Sci Rep. 2015 Nov 24;5:17201.

2014

  1. Wu B, Li C(李春權), Du Z, Yao Q, Wu J, Feng L, Zhang P, Li S, Xu L*, Li E*. Sci Rep. 2014 Jun 23;4:5403.（SCI影響因子IF=5.1）
  2. Li F, Xu Y, Shang D, Yang H, Liu W, Han J, Sun Z, Yao Q, Zhang C, Ma J, Su F, Feng L, Shi X, Zhang Y, Li J, Gu Q, Li X*, Li C (李春權)*. MPINet: metabolite pathway identification via coupling of global metabolite network structure and metabolomic profile. Biomed Res Int. 2014;2014:325697.
  3. Wu B, Li C (李春權), Du Z, Zhou F, Xie J, Luo L, Wu J, Zhang P, Xu L*, Li E*. Functional analysis of the mRNA profile of neutrophil gelatinaseassociated lipocalin overexpression in esophageal squamous cell carcinoma using multiple bioinformatic tools. Mol Med Rep. 2014 Oct;10(4):1800-1812.
  4. Zhang C, Li C (李春權), Li J, Han J, Shang D, Zhang Y, Zhang W, Yao Q, Han L, Xu Y, Yan W, Bao Z, You G, Jiang T*, Kang C*, Li X*. PLoS One. 2014 May 8;9(5):e96908.
  5. Shang D, Li C (李春權), Yao Q, Yang H, Xu Y, Han J, Li J, Su F, Zhang Y, Zhang C, Li D*, Li X*. Prioritizing Candidate Disease Metabolites Based on Global Functional Relationships between Metabolites in the Context of Metabolic Pathways. PLoS One. 2014 Aug 25;9(8):e104934.
  6. Li J, Li C (李春權), Han J, Zhang C, Shang D, Yao Q, Zhang Y, Xu Y, Liu W, Zhou M, Yang H, Su F, Li X*. The detection of risk pathways, regulated by miRNAs, via the integration of sample-matched miRNA-mRNA profiles and pathway structure.J Biomed Inform. 2014 June;49:187-197.
  7. Chen S, Li C (李春權), Wu B, Zhang C, Liu C, Lin X, Wu X, Sun L, Chen B, Zhong Z*, Xu L*, Li E. Identification of differentially expressed genes and their subpathways in recurrent versus primary bone giant cell tumors. Int J Oncol. 2014 Sep;45(3):1133-1142.
  8. Li J, Zhang Y, Wang Y, Zhang C, Wang Q, Shi X, Li C (李春權), Zhang R*, Li X*. Functional combination strategy for prioritization of human miRNA target. Gene. 2014;533(1):132-141.

2013

  1. Li C (李春權), Han J, Yao Q, Zou C, Xu Y, Zhang C, Shang D, Zhou L, Sun Z, Li J, Zhang Y, Yang H, Gao X*, Li X*. . Nucleic acids research. 2013;41(9):e101.（SCI影響因子IF=8.8）
  2. Liu W, Li C (李春權), Xu Y, Yang H, Yao Q, Han J, Shang D, Zhang C, Su F, Li X, Xiao Y, Zhang F, Dai M*, Li X*. Topologically inferring risk-active pathways toward precise cancer classification by directed random walk. Bioinformatics. 2013;29(17):2169-2177.（SCI影響因子IF=5.3）
  3. Wu B, Luo L, Li C (李春權), Xie J, Du Z, Wu J, Zhang P, Xu L*, Li E*. Comprehensive bioinformation analysis of the mRNA profile of fascin knockdown in esophageal squamous cell carcinoma. Asian Pacific journal of cancer prevention : APJCP. 2013;14(12):7221-7227.
  4. Shi H, Xu J, Zhang G, Xu L, Li C (李春權), Wang L, Zhao Z, Jiang W, Guo Z*, Li X*. Walking the interactome to identify human miRNA-disease associations through the functional link between miRNA targets and disease genes. BMC systems biology. 2013;7:101.
  5. Zhang F, Gao B, Xu L, Li C (李春權), Hao D, Zhang S, Zhou M, Su F, Chen X, Zhi H, Li X*. Allele-specific behavior of molecular networks: understanding small-molecule drug response in yeast. PLoS One. 2013;8(1):e53581.
  6. Wu B, Li C (李春權), Zhang P, Yao Q, Wu J, Han J, Liao L, Xu Y, Lin R, Xiao D, Xu L, Li E*, Li X*. Dissection of miRNA-miRNA interaction in esophageal squamous cell carcinoma. PLoS One. 2013;8(9):e73191.

2012

  1. Qiu F, Xu Y*, Li K, Li Z, Liu Y, DuanMu H, Zhang S, Chang Z, Zhou Y, Zhang R, Li C (李春權), Zhang Y, Liu M, Li X. CNVD: text mining-based copy number variation in disease database. Human mutation. 2012;33(11):E2375-81.（SCI影響因子IF=6.0）
  2. Li C (李春權), Han J, Shang D, Li J, Wang Y, Zhang Y, Yao Q, Zhang C, Li K*, Li X*. 2012;503(1):101-109.
  3. Li C (李春權), Shang D, Wang Y, Li J, Han J, Wang S, Yao Q, Wang Y, Zhang Y, Zhang C, Xu Y, Jiang W, Li X*.Characterizing the network of drugs and their affected metabolic subpathways. PLoS One. 2012;7(10):e47326.

2011

  1. Xu J, Li C, Li Y, Lv J, Ma Y, Shao T, Xu L, Wang Y, Du L, Zhang Y, Jiang W, Li C (李春權), Xiao Y, Li X*. MiRNA-miRNA synergistic network: construction via co-regulating functional modules and disease miRNA topological features. Nucleic acids research. 2011;39(3):825-836.（SCI影響因子IF=8.0）
  2. Li X*, Li C (李春權), Shang D, Li J, Han J, Miao Y, Wang Y, Wang Q, Li W, Wu C, Zhang Y, Li X, Yao Q. PLoS One. 2011;6(6):e21131.
  3. Li J, Gong B, Chen X, Liu T, Wu C, Zhang F, Li C (李春權), Li X*, Rao S*. DOSim: an R package for similarity between diseases based on Disease Ontology. BMC bioinformatics. 2011;12:266.
  4. Qiao W, Cheng H, Li C (李春權), Jin H, Yang S, Li X, Zhang Y*. Identification of pathways involved in paclitaxel activity in cervical cancer. Asian Pacific journal of cancer prevention : APJCP. 2011;12(1):99-102.

2009

  1. Li C (李春權), Li X*, Miao Y, Wang Q, Jiang W, Xu C, Li J, Han J, Zhang F, Gong B, Xu L. Nucleic acids research. 2009;37(19):e131.（SCI影響因子IF=7.8）

相關詞條

熱門詞條

聯絡我們